BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25246990)

  • 1. Expression of p27Kip1 and E-cadherin in Head and Neck Squamous Cell Carcinoma of Indonesian Patients.
    E I A; V J; D R H; A T S; A W S; K E; M A I
    Open Dent J; 2014; 8():136-43. PubMed ID: 25246990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p27
    DE Almeida MR; Pérez-Sayáns M; Suárez-Peñaranda JM; Somoza-Martín JM; García-García A
    Oncol Lett; 2015 Nov; 10(5):2675-2682. PubMed ID: 26722226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas.
    Motti ML; Califano D; Baldassarre G; Celetti A; Merolla F; Forzati F; Napolitano M; Tavernise B; Fusco A; Viglietto G
    Carcinogenesis; 2005 Jun; 26(6):1021-34. PubMed ID: 15718252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of E-cadherin/beta-catenin complex and cyclin D1 in head and neck squamous cell carcinoma.
    Do NY; Park SY; Lim SC
    Cancer Res Treat; 2004 Feb; 36(1):72-8. PubMed ID: 20396569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the E-cadherin-catenin cell adhesion complex in primary squamous cell carcinomas of the head and neck and their nodal metastases.
    Andrews NA; Jones AS; Helliwell TR; Kinsella AR
    Br J Cancer; 1997; 75(10):1474-80. PubMed ID: 9166940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
    St John MA
    Laryngoscope; 2015 Mar; 125 Suppl 3():S1-11. PubMed ID: 25646683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of p27(kip1) in metastatic laryngeal squamous cell carcinoma.
    Bodnar M; Szylberg Ł; Kaźmierczak W; Marszałek A
    Adv Med Sci; 2014 Sep; 59(2):206-12. PubMed ID: 25323759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of E-cadherin and cyclin D1 as predictive markers of aggression and clonal expansion in head and neck squamous cell carcinoma.
    Shergill K; Sen A; Pillai HJ
    J Korean Assoc Oral Maxillofac Surg; 2018 Aug; 44(4):182-190. PubMed ID: 30181985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1).
    Patel V; Lahusen T; Leethanakul C; Igishi T; Kremer M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS; Senderowicz AM
    Clin Cancer Res; 2002 Nov; 8(11):3549-60. PubMed ID: 12429646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of E-cadherin and p27 expression is associated with head and neck squamous tumorigenesis.
    Massarelli E; Brown E; Tran NK; Liu DD; Izzo JG; Lee JJ; El-Naggar AK; Hong WK; Papadimitrakopoulou VA
    Cancer; 2005 Mar; 103(5):952-9. PubMed ID: 15666322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANO1 Expression Orchestrates p27Kip1/MCL1-Mediated Signaling in Head and Neck Squamous Cell Carcinoma.
    Filippou A; Pehkonen H; Karhemo PR; Väänänen J; Nieminen AI; Klefström J; Grénman R; Mäkitie AA; Joensuu H; Monni O
    Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33803266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA MEG3 decreases the growth of head and neck squamous cell carcinoma by regulating the expression of miR-421 and E-cadherin.
    Ji Y; Feng G; Hou Y; Yu Y; Wang R; Yuan H
    Cancer Med; 2020 Jun; 9(11):3954-3963. PubMed ID: 32277605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome.
    Mattijssen V; Peters HM; Schalkwijk L; Manni JJ; van 't Hof-Grootenboer B; de Mulder PH; Ruiter DJ
    Int J Cancer; 1993 Oct; 55(4):580-5. PubMed ID: 8406985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-cadherin expression is involved in malignant behavior of head and neck cancer in relation to epithelial-mesenchymal transition.
    Nguyen PT; Kudo Y; Yoshida M; Kamata N; Ogawa I; Takata T
    Histol Histopathol; 2011 Feb; 26(2):147-56. PubMed ID: 21154228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the cell-cell adhesion molecule E-cadherin in squamous cell carcinoma of the head and neck.
    Bowie GL; Caslin AW; Roland NJ; Field JK; Jones AS; Kinsella AR
    Clin Otolaryngol Allied Sci; 1993 Jun; 18(3):196-201. PubMed ID: 8365008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells.
    Di Gennaro E; Barbarino M; Bruzzese F; De Lorenzo S; Caraglia M; Abbruzzese A; Avallone A; Comella P; Caponigro F; Pepe S; Budillon A
    J Cell Physiol; 2003 Apr; 195(1):139-50. PubMed ID: 12599217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low expression of p27(Kip1) in advanced mucoepidermoid carcinomas of head and neck.
    Choi CS; Choi G; Jung KY; Choi JO; Chae YS
    Head Neck; 2001 Apr; 23(4):292-7. PubMed ID: 11400230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta-crystallin enhancer binding factor 1 controls the epithelial to mesenchymal transition phenotype and resistance to the epidermal growth factor receptor inhibitor erlotinib in human head and neck squamous cell carcinoma lines.
    Haddad Y; Choi W; McConkey DJ
    Clin Cancer Res; 2009 Jan; 15(2):532-42. PubMed ID: 19147758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proinflammatory mediators upregulate snail in head and neck squamous cell carcinoma.
    St John MA; Dohadwala M; Luo J; Wang G; Lee G; Shih H; Heinrich E; Krysan K; Walser T; Hazra S; Zhu L; Lai C; Abemayor E; Fishbein M; Elashoff DA; Sharma S; Dubinett SM
    Clin Cancer Res; 2009 Oct; 15(19):6018-27. PubMed ID: 19789323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased E-cadherin but not beta-catenin expression is associated with vascular invasion and decreased survival in head and neck squamous carcinomas.
    Kurtz KA; Hoffman HT; Zimmerman MB; Robinson RA
    Otolaryngol Head Neck Surg; 2006 Jan; 134(1):142-6. PubMed ID: 16399195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.